Determinación del tiempo transcurrido desde la admisión hasta el diagnóstico e inicio del tratamiento en pacientes con linfoma de Hodgkin : impacto en la sobrevida global de la enfermedad. Hospital Solca Guayaquil enero 2012 – mayo 2017.

Abstract

Lymphomas are the neoplasms of the lymphohematopoietic system that affect the lymph nodes, bone marrow, spleen, tonsils, thymus, etc. In general terms, they are classified into two main groups: Hodgkin lymphoma (LH) and non-Hodgkin lymphoma (NHL). Biopsy of an affected lymph node or tumor sample is the only way to make a definitive diagnosis of lymphoma, added to a good clinical history and experience of the pathologist in determining the subtype of lymphoma of a specific patient. The two arms of treatment for radiotherapy and chemotherapy. Materials and Methods: retrospective, observational and analytical cohort study. Data were obtained from a registry containing patients with histopathological diagnosis performed / confirmed in the Department of Pathology of SOLCA Guayaquil from January 2012 to May 2017. Results: A total of 125 patients were recruited, the average time definitive diagnosis of 43 days receiving an optimal 21 days to determine. The optimal time from the first examination with the doctor that the diagnosis until the start of treatment was 21 days and the median of 49 days. Conclusions: In the present study, there was no evidence between the early diagnosis and timely treatment with the survival and prognosis of the patient with Hodgkin Lymphoma. The diagnosis in pediatric patients compared to adults was faster, although it had no impact on survival.